Keensight-backed Symeres snaps up DGr Pharma

DGr Pharma is a drug development-focused company.

10 September 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.